Background Before the COVID-19 pandemic, coronaviruses caused two noteworthy outbreaks:
severe acute respiratory syndrome (SARS), starting in 2002, and Middle East respiratory …

There is accumulating evidence of the neurological and neuropsychiatric features of infection
with SARS-CoV-2. In this systematic review and meta-analysis, we aimed to describe the …

Early in the pandemic, concerns were raised about the potential for serious and widespread
neurological and psychiatric adverse outcomes following COVID-19, on the basis of a …

We examine how the market's ability to assess the truthfulness of management earnings
forecasts affects how managers bias their forecasts, and we evaluate whether the market's …

We examine the relation between disclosure tone and shareholder litigation to determine
whether managers' use of optimistic language increases litigation risk. Using both general-…

We examine changes in the disclosure behavior of firms involved in 827 disclosure-related
class-action securities litigation cases filed between 1996 and 2005. We find no evidence …

The nature and extent of persistent neuropsychiatric symptoms after COVID-19 are not
established. To help inform mental health service planning in the pandemic recovery phase, we …

This study examines whether managers strategically alter disclosure “quality” in response to
personal incentives, specifically those derived from trading on their own account. Using …

We study the effect of disclosure on uncertainty by examining how management earnings
forecasts affect stock market volatility. Using implied volatilities from exchange-traded options …

Microalgae have been promoted as the next frontier of green biotechnology and gained
widespread attention as desirable feedstocks for biofuels. Using conservative assumptions for …